WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017066772) PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/066772    International Application No.:    PCT/US2016/057369
Publication Date: 20.04.2017 International Filing Date: 17.10.2016
IPC:
C07K 14/005 (2006.01), C07K 14/01 (2006.01), C12N 7/00 (2006.01), A61K 39/12 (2006.01), A61P 31/12 (2006.01)
Applicants: KANSAS STATE UNIVERSITY RESEARCH FOUNDATION [US/US]; 2005 Research Park Circle Suite 105 Manhattan, Kansas 66502 (US)
Inventors: HAUSE, Ben; (US)
Agent: TRUITT, Tracey; (US)
Priority Data:
62/242,866 16.10.2015 US
Title (EN) PORCINE CIRCOVIRUS TYPE 3 IMMUNOGENIC COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
(FR) COMPOSITIONS IMMUNOGÈNES CONTRE LE CIRCOVIRUS PORCIN DE TYPE 3 ET PROCÉDÉS DE FABRICATION ET D'UTILISATION ASSOCIÉS
Abstract: front page image
(EN)A new species of circovirus, porcine circovirus type 3 (PCV3), was identified from sows with clinical symptoms normally associated with porcine circovirus type 2 (PCV2) infection and in aborted fetuses. Molecular and serological analyses suggest PCV3 commonly circulates in U.S. swine. The present disclosure provides immunological compositions and methods related to the production and administration of such compositions.
(FR)Une nouvelle espèce de circovirus, le circovirus porcin de type 3 (PCV3), a été identifiée chez des truies présentant des symptômes cliniques normalement associés à une infection par le circovirus porcin de type 2 (PCV2) et chez des fœtus avortés. Des analyses moléculaires et sérologiques suggèrent que le PCV3 circule communément chez les porcs aux États-Unis. La présente invention concerne des compositions immunologiques et des procédés liés à la production et l'administration de ces compositions.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)